12‐hydroxy‐eicosatetraenoic acid (12‐HETE): a biomarker of Churg‐Strauss syndrome
- 13 December 2011
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 42 (4) , 513-522
Abstract
Summary: Background: Churg‐Strauss syndrome (CSS) shares similarities with asthma and hypereosinophilic syndrome (HES). Eicosanoids – important inflammatory and signaling molecules – are present in exhaled breath condensate (EBC) and broncho‐alveolar lavage fluid (BALF).Objectives: To assess eicosanoid profile both inEBCandBALFofCSSsubjects searching for a pattern characteristic of this syndrome.Methods: EBCs from 23CSSpatients, 30 asthmatics, 12HESpatients and 54 healthy controls (HC) were assessed quantitatively for 19 eicosanoids by a high‐performance liquid chromatography ‐ tandem mass spectrometry (HPLC‐MS/MS). In addition, in 21 of 23CSSsubjects and in nine asthmatics, eicosanoids were determined inBALF.Results: EBCfromCSSpatients showed markedly elevated levels of 12‐HETEas compared with other studied groups.BALFwas characterized by a significant elevation of 12‐HETEand its metabolite 12‐tetranorHETEinCSSas compared with asthma. Clinical activity ofCSScorrelated with 12‐HETEand its metabolites levels inBALF, but not inEBC.Conclusion and Clinical Relevance: CSSis clearly distinguished from bronchial asthma, andHESby a marked increase in 12‐HETEconcentration in bothEBCandBALF. This points to a possible new pathogenic mechanism inCSSand may help in future in establishing the diagnosis ofCSS.Keywords
This publication has 43 references indexed in Scilit:
- Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotypeJournal of Allergy and Clinical Immunology, 2011
- Relationship Between Markers of Platelet Activation and Inflammation with Disease Activity in Wegener’s GranulomatosisThe Journal of Rheumatology, 2011
- Functional and pathological roles of the 12- and 15-lipoxygenasesProgress in Lipid Research, 2011
- Eoxins: A new inflammatory pathway in childhood asthmaJournal of Allergy and Clinical Immunology, 2010
- Novel Lipid Mediators and Resolution Mechanisms in Acute InflammationThe American Journal of Pathology, 2010
- Practical approach to the patient with hypereosinophiliaJournal of Allergy and Clinical Immunology, 2010
- Refining the definition of hypereosinophilic syndromeJournal of Allergy and Clinical Immunology, 2010
- Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndromeRheumatology, 2009
- Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research ProgramJournal of Allergy and Clinical Immunology, 2007
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975